Nibbling versus feasting: Which meal pattern is better for heart disease prevention?

Nutrition Reviews

Volumn 67, Issue 10, 2009, Pages 591-598

  Bhutani, Surabhi ^a   Varady, Krista A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Cholesterol; Coronary heart disease; Feasting; Meal frequency; Nibbling

Indexed keywords

3 HYDROXY 3 METHYLGLUTARYL COENZYME A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SATURATED FATTY ACID; TRIACYLGLYCEROL; LIPID;

ATHEROGENIC DIET; BLOOD PRESSURE; BLOOD SAMPLING; CALORIC INTAKE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; DIET THERAPY; ENERGY CONSUMPTION; FEASTING MEAL PATTERN; FEEDING BEHAVIOR; FOOD INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LIPID BLOOD LEVEL; LIPID DIET; LIPOPROTEIN BLOOD LEVEL; METABOLIC DISORDER; NIBBLING MEAL PATTERN; REVIEW; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; BLOOD; CORONARY ARTERY DISEASE; CROSSOVER PROCEDURE; DAILY LIFE ACTIVITY; EATING; FEMALE; LOW FAT DIET; MALE; OBESITY; PHYSIOLOGY;

ACTIVITIES OF DAILY LIVING; APOLIPOPROTEIN A-I; APOLIPOPROTEINS B; BIOLOGICAL MARKERS; BLOOD PRESSURE; CLINICAL TRIALS AS TOPIC; CORONARY DISEASE; CROSS-OVER STUDIES; DIET, FAT-RESTRICTED; EATING; FEMALE; HUMANS; LIPIDS; MALE; OBESITY;

EID: 70350741369     PISSN: 00296643     EISSN: 17534887     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2009.00231.x     Document Type: Review

References (38)

1. Centers for Disease Control. Summary Health Statistics for U.S. Adults: National Health Interview Survey.Washington, DC: U.S. Department for Health and Human Services; 2006.
2. Carmena R, Duriez P, Fruchart JC. Atherogenic lipoprotein particles in atherosclerosis. Circulation. 2004;109:III2-7.
3. National Cholesterol Education Program. Third Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Washington, DC: National Heart, Lung, and Blood Institute; 2002.
4. Women's Health Initiative Study Group. Dietary adherence in theWomen's Health Initiative DietaryModification Trial. J Am Diet Assoc. 2004;104:654-658.
5. Stote KS, Baer DJ, Spears K, et al. A controlled trial of reduced meal frequency without caloric restriction in healthy, normalweight, middle-aged adults. Am J Clin Nutr. 2007;85:981-988.
6. McGrath SA, Gibney MJ. The effects of altered frequency of eating on plasma lipids in free-living healthy males on normal self-selected diets. Eur J Clin Nutr. 1994;48:402-407.
7. Jenkins DJ, Wolever TM, Vuksan V, et al. Nibbling versus gorging: metabolic advantages of increased meal frequency. N Engl J Med. 1989;321:929-934.
8. MurphyMC, Chapman C, Lovegrove JA, et al.Meal frequency; does it determine postprandial lipaemia? Eur J Clin Nutr. 1996;50:491-497.
9. Arnold LM, Ball MJ, Duncan AW,Mann J. Effect of isoenergetic intake of three or nine meals on plasma lipoproteins and glucose metabolism. Am J Clin Nutr. 1993;57:446-451.
10. Arnold L, Ball M, Mann J. Metabolic effects of alterations in meal frequency in hypercholesterolaemic individuals. Atherosclerosis. 1994;108:167-174.
11. Farshchi HR, Taylor MA, Macdonald IA. Regular meal frequency creates more appropriate insulin sensitivity and lipid profiles compared with irregular meal frequency in healthy lean women. Eur J Clin Nutr. 2004;58:1071-1077.
12. Farshchi HR, Taylor MA, Macdonald IA. Beneficial metabolic effects of regular meal frequency on dietary thermogenesis, insulin sensitivity, and fasting lipid profiles in healthy obese women. Am J Clin Nutr. 2005;81:16-24.
13. Pischon T, Girman CJ, Sacks FM, Rifai N, Stampfer MJ, Rimm EB. Non-high-density lipoprotein cholesterol and apolipoprotein B in the prediction of coronary heart disease in men. Circulation. 2005;112:3375-3383. (Pubitemid 43739551)
14. Miller M, Ginsberg HN, Schaefer EJ. Relative atherogenicity and predictive value of non-high-density lipoprotein cholesterol for coronary heart disease. Am J Cardiol. 2008;101:1003-1008.
15. Hill AM, Kris-Etherton PM. Contemporary strategies for weight loss and cardiovascular disease risk factor modification. Curr Atheroscler Rep. 2008;10:486-496.
16. Brunner EJ, Rees K, Ward K, Burke M, Thorogood M. Dietary advice for reducing cardiovascular risk. Cochrane Database Syst Rev. 2007;CD002128.
17. Hutton B, Fergusson D. Changes in body weight and serum lipid profile in obese patients treated with orlistat in addition to a hypocaloric diet: a systematic review of randomized clinical trials. Am J Clin Nutr. 2004;80:1461-1468.
18. Preiss D, Sattar N. Lipids, lipid modifying agents and cardiovascular risk: a review of the evidence. Clin Endocrinol (Oxf). 2009;70:815-828.
19. Scanu AM, Edelstein C. HDL: bridging past and present with a look at the future. FASEB J. 2008;22:4044-4054.
20. Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Heart. 2008;94:706-714.
21. Kelley GA, Kelley KS. Aerobic exercise and lipids and lipoproteins in men: a meta-analysis of randomized controlled trials. J Mens Health Gend. 2006;3:61-70.
22. Gandotra P, Miller M. The role of triglycerides in cardiovascular risk. Curr Cardiol Rep. 2008;10:505-511.
23. Abdel-Maksoud M, Sazonov V, Gutkin SW, Hokanson JE. Effects of modifying triglycerides and triglyceride-rich lipoproteins on cardiovascular outcomes. J Cardiovasc Pharmacol. 2008;51:331-351.
24. van der Meer RW, Hammer S, Lamb HJ, et al. Effects of shortterm high-fat, high-energy diet on hepatic and myocardial triglyceride content in healthy men. J Clin Endocrinol Metab. 2008;93:2702-2708.
25. Taku K, Umegaki K, Sato Y, Taki Y, Endoh K, Watanabe S. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. Am J Clin Nutr. 2007;85:1148-1156.
26. Robinson JG,Wang S, Smith BJ, Jacobson TA.Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. J Am Coll Cardiol. 2009;53:316-322.
27. Karalis DG. The role of advanced lipid testing in clinical practice. Prev Cardiol. 2007;10:228-234.
28. Sailam V, Karalis DG, Agarwal A, et al. Prevalence of emerging cardiovascular risk factors in younger individuals with a family history of premature coronary heart disease and low Framingham risk score. Clin Cardiol. 2008;31:542-545.
29. Tardif JC, Heinonen T, Noble S. High-density lipoprotein/ apolipoprotein A-I infusion therapy. Curr Atheroscler Rep. 2009;11:58-63.
30. Hausenloy DJ, Yellon DM. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels. Postgrad Med J. 2008;84:590-598.
31. Plump AS, Scott CJ, Breslow JL. Human apolipoprotein A-I gene expression increases high density lipoprotein and suppresses atherosclerosis in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 1994;91:9607-9611.
32. Leon AS, Sanchez OA. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc. 2001;33(Suppl):S502-S515. discussion S28- 29.
33. Herzberg GR. Aerobic exercise, lipoproteins, and cardiovascular disease: benefits and possible risks. Can J Appl Physiol. 2004;29:800-807.
34. Andrikoula M, McDowell IF. The contribution of ApoB and ApoA1 measurements to cardiovascular risk assessment. Diabetes Obes Metab. 2008;10:271-278.
35. Thompson A, Danesh J. Associations between apolipoprotein B, apolipoprotein AI, the apolipoprotein B/AI ratio and coronary heart disease: a literature-based meta-analysis of prospective studies. J Intern Med. 2006;259:481-492.
36. van den Hoogen PC, Feskens EJ, Nagelkerke NJ, Menotti A, Nissinen A, Kromhout D. The relation between blood pressure and mortality due to coronary heart disease among men in different parts of the world. Seven Countries Study Research Group. N Engl J Med. 2000;342:1-8.
37. Stamler J, Stamler R, Neaton JD. Blood pressure, systolic and diastolic, and cardiovascular risks. US population data. Arch Intern Med. 1993;153:598-615.
38. He FJ, MacGregor GA. Effect of longer-term modest salt reduction on blood pressure. Cochrane Database Syst Rev. 2004;CD004937